* Type 2 Diabetes - Case Study 01 (Prior History) Male: 60 years, Height: 5 ft. 6 inches, Weight = 75.454 Kg (166.0 lbs.), Fat = 23.2% (0) Anti-Diabetic Rx = Eurepa MF2 (Repaglinide XL 50mg) + Metformin 500 mg + Insulin Breakfast = 40 units + Dinner = 20 units = 60 units/day SERUM TESTS 26/11/2010 27/12/2010 13/1/2011 31/01/2011 1/3/2011 2/4/2011 23/08/2011 26/09/2011 FBS mg/dL (Urine) PPBS mg/dL (Urine) Insulin - Fast uIU/mL Insulin - PP uIU/mL Ferritin ng/mL BUN mg/dL Creatinine mg/dL Uric Acid mg/dL Anit-Hypertesive Rx = Tazloc H (Telmisartan 40 mg + HCTZ 12.5 mg) + Selomax XL (Metoprolol XL 50 mg + Amlodipine 5 mg) 24/09/2011 BPs Ps bpm Notes: * All these readings are before starting the program at SpaceAge Anti-Aging Center in November 2011 General observations are that the blood sugar levels are not under control inspite of numerous anti-diabetic medications and insulin, the hemoglobin has decreased to around 11.5 g/dL due to prolonged use of aspirin resulting in poor energy levels and the uric acid levels have significantly increased to 6.0 mg/dL showing gradually deteriorating kidney function due to uncontrolled diabetes. Sugar is present in the urine at (++++) level. Reversing Type 2 Diabetes - Case Study 01 Male: 60 years, Height: 5 ft. 6 inches, Weight = 75.454 Kg (166.0 lbs.), Fat = 23.2% (0) Anti-Diabetic Rx = Eurepa MF2 (Repaglinide 2 mg + Metformin 500 mg) + Humalog Mix BkF = 32 units + D = 20 units = 52 units/day Januvia (Sitagliptin Phosphate) 100 mg + Diamicron XR (Gliclazide) 60 mg + Novonorm (Repaglinide 2 mg) Interim Goal While on Program, FBS = 140 mg/dL, PPBS = 180 mg/dL. This is to ensure patient does not go Hypoglycemic SERUM TESTS * 23/08/11 * 23/11/11 24/12/11 20/03/12 18/08/12 12/11/12 FBS mg/dL PPBS mg/dL (Urine) Insulin - Fast uIU/mL Insulin - PP uIU/mL Ferritin ng/mL BUN mg/dL Creatinine mg/dL Uric Acid mg/dL Cystatin C mg/L (Numerous Crystals in both Kidneys) Anit-Hypertesive Rx = Tazloc Trio (Telmisartan 40 mg + Amlodipine 5 mg + HCTZ 12.5 mg) + Seloken XL (Metoprolol XL 50 mg) Interim Goal While on Program, BP = 140 / 90, P = 85 bpm. This is to ensure patient does not suffer Hypotension or Bradycardia * 24/09/11 * 17/11/11 23/01/12 12/3/2012 24/04/12 14/07/12 15/10/12 BPs mm Hg standing (LVEF = 60%) Notes: * These readings are before starting the program at SpaceAge Anti-Aging Center in Nov 2011 General observations are that the blood sugar levels are under better control with anti-diabetic medication and insulin, the hemoglobin has increased to around 12.7 g/dL resulting in improved energy levels and better physical stamina; there is a significant improvement in Ferritin levels showing a fair reserve of iron at intracellular levels; and there is no further increase in uric acid levels showing no further deterioration of kidney function; and there is a much better control of diabetes. Sugar is no longer present in the urine. Insulin levels have been steadily brought down without any deterioration of HbA1C. Reversing Type 2 Diabetes - Case Study 01 - Part 2 Male: 60 years, Height: 5 ft. 6 inches, Weight = 75.454 Kg (166.0 lbs.), Fat = 23.2% (0) Anti-Diabetic Rx = Eurepa 2 (Repaglinide 2 mg) + Humalog Mix = 26 units at Breakfast + 10 units at Dinner = 36 units/day Januvia (Sitagliptin Phosphate) 100 mg + Diamicron XR (Gliclazide) 60 mg Interim Goal While on Program, FBS = 140 mg/dL, PPBS = 180 mg/dL. This is to ensure patient does not go Hypoglycemic SERUM TESTS * 23/08/11 * 23/11/11 24/12/11 20/03/12 18/08/12 12/11/12 4/2/2013 FBS mg/dL PPBS mg/dL (Urine) Insulin - Fast uIU/mL Insulin - PP uIU/mL Ferritin ng/mL BUN mg/dL Creatinine mg/dL Uric Acid mg/dL Cystatin C mg/L (Numerous Crystals in both Kidneys) Anit-Hypertesive Rx = Tazloc (Telmisartan 40 mg) + Seloken XL (Metoprolol XL 50 mg) Interim Goal While on Program, BP = 140 / 90, P = 85 bpm. This is to ensure patient does not suffer Hypotension or Bradycardia * 24/09/11 * 17/11/11 23/01/12 12/3/2012 24/04/12 14/07/12 15/10/12 BPs mm Hg standing (LVEF = 60%) Notes: * These readings are before starting the program at SpaceAge Anti-Aging Center in Nov 2011 General observations are that blood sugar levels are under better control with anti-diabetic medication & insulin. Hb has increased to 13.1 g/dL resulting in improved energy levels and better physical stamina; there is a significant improvement in Ferritin = 89.4 ng/mL showing a fair reserve of iron at intracellular levels; and there is a significant drop in uric acid levels from a high of 6.5 mg/dL to 3.60 mg/dL showing an improvemnt of kidney function; and there is a much better control of diabetes. Sugar is no longer present in the urine. Insulin levels have been steadily brought down to 26 + 10 = 36 units/day without any deterioration of HbA1C.
Compiled by Corporate Catalyst (India) Pvt Ltd Period: September 1 – September 7, 2012 MARKET MOVEMENT Major Indices August 31, 2012 September 7, 2012 % Change Change POLICY WATCH Commerce Ministry in favour of unrestricted exports of processed foods Delhi-Mumbai Industrial Corridor project gets approval to access ECB India seeks Japan's support for
Chiese bizantine ed escursione a Famagosta 25 aprile/2 maggio 2009 ITINERARIO: CUNEO – MILANO – LARNACA – LIMASSOL – KAKOPETRIA - NICOSIA – KERYNIA – CURIUM – PAPHOS – CIPRO DEL NORD – FAMAGOSTA – SALAMINA – LARNACA – MILANO – CUNEO DURATA DEL VIAGGIO: 8 GIORNI (7 NOTTI) TRASPORTO: VOLO DI LINEA SISTEMAZIONE: HOTEL 3 STELLE TRATTAMENTO: M